YAP1 and cancer: Moreover, a meta-analysis that included various cancers showed that YAP1 positivity is significantly associated with poor overall survival (HR = 1.83, 95% CI 1.47–2.28) and disease-free survival (HR = 2.11, 95% CI 1.41–3.18) (88).